T-Regulatory Cells and Vaccination “Pay Attention and Do Not Neglect Them”: Lessons from HIV and Cancer Vaccine Trials

Efficient vaccines are characterized by the establishment of long-lived memory T cells, including T-helper (effectors and follicular) and T-regulatory cells (Tregs). While the former induces cytotoxic or antibody responses, the latter regulates immune responses by maintaining homeostasis. The role o...

Full description

Bibliographic Details
Main Authors: Vedran Brezar, Véronique Godot, Liang Cheng, Lishan Su, Yves Lévy, Nabila Seddiki
Format: Article
Language:English
Published: MDPI AG 2016-09-01
Series:Vaccines
Subjects:
Online Access:http://www.mdpi.com/2076-393X/4/3/30
_version_ 1811299482220888064
author Vedran Brezar
Véronique Godot
Liang Cheng
Lishan Su
Yves Lévy
Nabila Seddiki
author_facet Vedran Brezar
Véronique Godot
Liang Cheng
Lishan Su
Yves Lévy
Nabila Seddiki
author_sort Vedran Brezar
collection DOAJ
description Efficient vaccines are characterized by the establishment of long-lived memory T cells, including T-helper (effectors and follicular) and T-regulatory cells (Tregs). While the former induces cytotoxic or antibody responses, the latter regulates immune responses by maintaining homeostasis. The role of Tregs in inflammatory conditions is ambiguous and their systematic monitoring in vaccination along with effector T-cells is not instinctive. Recent studies from the cancer field clearly showed that Tregs suppress vaccine-induced immune responses and correlate with poor clinical benefit. In HIV infection, Tregs are needed during acute infection to preserve tissue integrity from an overwhelmed activation, but are not beneficial in chronic infection as they suppress anti-HIV responses. Current assays used to evaluate vaccine-induced specific responses are limited as they do not take into account antigen-specific Tregs. However, new assays, such as the OX40 assay, which allow for the simultaneous detection of a full range of Th-responses including antigen-specific Tregs responses, can overcome these issues. In this review article we will revise the role of Tregs in vaccination and review the recent work performed in the field, including the available tools to monitor them, from novel assays to humanized mouse models.
first_indexed 2024-04-13T06:36:37Z
format Article
id doaj.art-86dcbd55882749c38f74986bb62090e8
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-04-13T06:36:37Z
publishDate 2016-09-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-86dcbd55882749c38f74986bb62090e82022-12-22T02:57:54ZengMDPI AGVaccines2076-393X2016-09-01433010.3390/vaccines4030030vaccines4030030T-Regulatory Cells and Vaccination “Pay Attention and Do Not Neglect Them”: Lessons from HIV and Cancer Vaccine TrialsVedran Brezar0Véronique Godot1Liang Cheng2Lishan Su3Yves Lévy4Nabila Seddiki5Institut National de la Santé et de la Recherche Médicale (INSERM), U955, Equipe 16, Créteil 94000, FranceInstitut National de la Santé et de la Recherche Médicale (INSERM), U955, Equipe 16, Créteil 94000, FranceDepartment of Microbiology and Immunology, Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USADepartment of Microbiology and Immunology, Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USAInstitut National de la Santé et de la Recherche Médicale (INSERM), U955, Equipe 16, Créteil 94000, FranceInstitut National de la Santé et de la Recherche Médicale (INSERM), U955, Equipe 16, Créteil 94000, FranceEfficient vaccines are characterized by the establishment of long-lived memory T cells, including T-helper (effectors and follicular) and T-regulatory cells (Tregs). While the former induces cytotoxic or antibody responses, the latter regulates immune responses by maintaining homeostasis. The role of Tregs in inflammatory conditions is ambiguous and their systematic monitoring in vaccination along with effector T-cells is not instinctive. Recent studies from the cancer field clearly showed that Tregs suppress vaccine-induced immune responses and correlate with poor clinical benefit. In HIV infection, Tregs are needed during acute infection to preserve tissue integrity from an overwhelmed activation, but are not beneficial in chronic infection as they suppress anti-HIV responses. Current assays used to evaluate vaccine-induced specific responses are limited as they do not take into account antigen-specific Tregs. However, new assays, such as the OX40 assay, which allow for the simultaneous detection of a full range of Th-responses including antigen-specific Tregs responses, can overcome these issues. In this review article we will revise the role of Tregs in vaccination and review the recent work performed in the field, including the available tools to monitor them, from novel assays to humanized mouse models.http://www.mdpi.com/2076-393X/4/3/30memory cellTregsHIVvaccineDC-based vaccineOX40CD25CD39hu-mice
spellingShingle Vedran Brezar
Véronique Godot
Liang Cheng
Lishan Su
Yves Lévy
Nabila Seddiki
T-Regulatory Cells and Vaccination “Pay Attention and Do Not Neglect Them”: Lessons from HIV and Cancer Vaccine Trials
Vaccines
memory cell
Tregs
HIV
vaccine
DC-based vaccine
OX40
CD25
CD39
hu-mice
title T-Regulatory Cells and Vaccination “Pay Attention and Do Not Neglect Them”: Lessons from HIV and Cancer Vaccine Trials
title_full T-Regulatory Cells and Vaccination “Pay Attention and Do Not Neglect Them”: Lessons from HIV and Cancer Vaccine Trials
title_fullStr T-Regulatory Cells and Vaccination “Pay Attention and Do Not Neglect Them”: Lessons from HIV and Cancer Vaccine Trials
title_full_unstemmed T-Regulatory Cells and Vaccination “Pay Attention and Do Not Neglect Them”: Lessons from HIV and Cancer Vaccine Trials
title_short T-Regulatory Cells and Vaccination “Pay Attention and Do Not Neglect Them”: Lessons from HIV and Cancer Vaccine Trials
title_sort t regulatory cells and vaccination pay attention and do not neglect them lessons from hiv and cancer vaccine trials
topic memory cell
Tregs
HIV
vaccine
DC-based vaccine
OX40
CD25
CD39
hu-mice
url http://www.mdpi.com/2076-393X/4/3/30
work_keys_str_mv AT vedranbrezar tregulatorycellsandvaccinationpayattentionanddonotneglectthemlessonsfromhivandcancervaccinetrials
AT veroniquegodot tregulatorycellsandvaccinationpayattentionanddonotneglectthemlessonsfromhivandcancervaccinetrials
AT liangcheng tregulatorycellsandvaccinationpayattentionanddonotneglectthemlessonsfromhivandcancervaccinetrials
AT lishansu tregulatorycellsandvaccinationpayattentionanddonotneglectthemlessonsfromhivandcancervaccinetrials
AT yveslevy tregulatorycellsandvaccinationpayattentionanddonotneglectthemlessonsfromhivandcancervaccinetrials
AT nabilaseddiki tregulatorycellsandvaccinationpayattentionanddonotneglectthemlessonsfromhivandcancervaccinetrials